• April 26, 2019

HitGen and Kaken Enter Into License Agreement - Odessa American: Business

e-Edition Subscribe

HitGen and Kaken Enter Into License Agreement

Font Size:
Default font size
Larger font size

Posted: Wednesday, April 10, 2019 9:01 pm | Updated: 9:30 pm, Wed Apr 10, 2019.

CHENGDU, China--(BUSINESS WIRE)--Apr 10, 2019--HitGen Inc. announced today that HitGen Inc. and Kaken Pharmaceutical Co., Ltd. have entered into a license agreement to develop a novel class of drugs. The licensed compounds were identified using HitGen’s leading technology platform, which involved screening large DNA encoded libraries, containing over 400 billion of small molecules with drug-like properties synthesized on chemically diverse scaffolds. A number of novel small molecule leads for an undisclosed target nominated by Kaken were the subject of this license agreement.

Under the terms of collaborative agreement, HitGen will grant exclusive rights to Kaken for further development and commercialization, and be eligible for preclinical and clinical milestone payments from Kaken as the project progresses, in addition to upfront license fee.

We are delighted to announce this significant project milestone. The success of delivery of these licensed compounds has further demonstrated the power of our DEL platform to discover novel small molecules against a variety of targets, including those previously challenging ones. We look forward to seeing the progress made by Kaken” said Dr. Jin Li, Chairman of the Board and Chief Executive Officer of HitGen.

About Kaken

Kaken (Tokyo Stock Exchange: 4521) is a specialty pharmaceutical company in Japan with strong experience in developing and commercializing novel pharmaceuticals and medical devices in the fields of orthopedics, dermatology and surgery. Kaken concentrates its R&D resources in inflammation/immunology (dermatitis, rheumatoid arthritis and osteoarthritis), pain relief and fungal infection areas.

For more information, please visit http://www.kaken.co.jp/english/

About HitGen Inc.

HitGen is a rapidly growing biotech company with headquarter and main research facility based in Chengdu, China and with a subsidiary in the USA. HitGen has established a platform for small molecule drug discovery research centred on the design, synthesis and screening of DNA encoded chemical libraries (DELs). HitGen’s DELs contain over 400 billion novel, diverse, drug-like small molecule and macrocyclic compounds. These compounds are members of DELs synthesised from many hundreds of distinct chemical scaffolds, designed with tractable chemistry, and yielded proven results for the discovery of small molecule leads against precedented and unprecedented classes of biological targets. HitGen is collaborating with pharmaceutical, biotech, and chemical companies, foundations and research institutes in North America, Europe, Asia and Africa to discover and develop approaches for novel medicines and other solutions.

For more information, please visit www.hitgen.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190410005950/en/

CONTACT: Dr. Jin Li, Chairman & CEO

HitGen Inc.

Tel: +86 28 85197385 (8001)



SOURCE: HitGen Inc.

Copyright Business Wire 2019.

PUB: 04/10/2019 10:01 PM/DISC: 04/10/2019 10:01 PM


© 2019 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Odessa, TX

Current Conditions

Humidity: 48%
Winds: ESE at 19mph
Feels Like: 65°

Your Extended Forecast


High 81°/Low 61°
More sun than clouds. Highs in the low 80s and lows in the low 60s.


High 91°/Low 62°
A few clouds. Highs in the low 90s and lows in the low 60s.


High 92°/Low 62°
Partly cloudy. Highs in the low 90s and lows in the low 60s.
Online Features

Pet Central


Having a pet is a lot of responsibility, and we’ll help by giving you lots of tips and tricks! More >>



Our fitness articles will help teach you how to work out with gym- and home-based exercises. More >>



Enjoy the crosswords challenge in our free daily puzzles, from the harder Sunday crossword to the quicker daily. More >>



Every Sudoku has a unique solution that can be reached logically. Enter numbers into the blank spaces so that each row, column and 3x3 box contains the numbers 1 to 9. More >>

  • ALL-ACCESS: Subscribe to our e-edition and premium website at myoaoa.com.
    You can read your daily newspaper without taking a walk to the driveway.
    Look back at yesterday's newspaper, or issues from months ago with our archive feature.
    Call circulation at 432-337-7670 to sign up today.